Side-by-side comparison of AI visibility scores, market position, and capabilities
Healthcare AI providing insurance eligibility verification in 6 seconds at 96% accuracy; $3.8M from YC and Kindred Capital serving Talkiatry with 8x ROI in behavioral health and telehealth.
Sohar Health is a healthcare AI company providing automated insurance eligibility and benefits verification for healthcare providers — delivering verification results in 6 seconds with 96% accuracy through a real-time API that replaces the manual insurance verification calls that consume significant administrative time at medical practices, behavioral health providers, and telehealth companies. The company raised $3.8 million in seed funding led by Kindred Capital and Y Combinator in March 2025, processes 60,000+ monthly eligibility checks, and serves providers including Talkiatry (a major telepsychiatry platform) while delivering 8x ROI for clients within 12 months.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.